Vision
Our mission
To foster collaboration among veterinary vaccine developers and manufacturers, advance innovative solutions, and advocate for equitable access to vaccines
Our vision
To achieve global accessibility and affordability of veterinary vaccines, tailored to diverse animal populations, strengthening resilience against infectious diseases
AVVM stems from the need to bridge the gap arising from the lack of balance in animal health and human health measures. The ultimate goal is to contribute to ‘One Health’ which can only be approached in a multidirectional manner, encompassing the need to address the issues of animal health more aggressively.
Objectives
Accelerate transition from R&D to manufacturing
Utilise AI, ML and CB tools, novel platform technologies, and scalable bioprocessing solutions
Harmonise regulatory landscape
Focusing on WHO-PQ* and defining QTTP* and TRS* for vaccines, in collaboration with stakeholders
Global funding and clinical trial support
Facilitate global funding and clinical trial support for R&D institutes and SME* manufacturers
Strengthen global production capacity
Facilitate capacity building, technology transfer, and prioritise training initiatives
Foster private-public partnerships
For collaboration in terms of R&D, production, cold chain storage, and supply chain
Promote sustainability
Minimise environmental impact in vaccine production and supply chain